Literature DB >> 26603235

A NEW POSSIBILITY FOR SURVEILLANCE: DO WE IDENTIFY ALL CASES OF LEPTOSPIROSIS?

Raissa Matos Fontes1, Luciano Pamplona de Góes Cavalcanti1, Augusto César Aragão Oliveira1, Laiane Fernanda de Melo Bezerra1, Almira Maria Monteiro Gomes1, Jeová Keny Baima Colares1, Danielle Malta Lima1.   

Abstract

Leptospirosis is a febrile disease with a typically underestimated global incidence, especially in regions where dengue is endemic. Therefore, it is difficult to accurately determine the number of leptospirosis cases in these areas, which contributes to significant under-reporting this disease. In this study, we estimated the number of possible leptospirosis cases among dengue-like cases that were reported during 2008, 2010, and 2012 in the city of Fortaleza, northeast Brazil. Patients were evaluated for dengue and leptospirosis using immunoenzymatic tests for IgM antibodies that were specific to each pathogen. Among the suspected cases of dengue that resulted as negative in laboratory tests, 10.8% (2008), 19.2% (2010), and 30.8% (2012) were confirmed to be leptospirosis. Considering the cases reported by the surveillance authority as dengue that were subsequently discarded based on the laboratory test results, we estimate that the number of actual leptospirosis cases may be 26 to 49 times higher than those diagnosed and reported by the Health Services. Furthermore, we believe that approximately 20% of dengue-like cases may be leptospirosis cases in areas where the two diseases are endemic.

Entities:  

Mesh:

Year:  2015        PMID: 26603235      PMCID: PMC4660457          DOI: 10.1590/S0036-46652015000500014

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  20 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  A hospital-based study on seroprevalence of leptospirosis among febrile cases in northeastern Malaysia.

Authors:  A A Noor Rafizah; B D Aziah; Y N Azwany; M Kamarul Imran; A Mohamed Rusli; S Mohd Nazri; A Mohd Nikman; I Nabilah; H Siti Asma'; W M Zahiruddin; I Zaliha
Journal:  Int J Infect Dis       Date:  2013-01-26       Impact factor: 3.623

4.  Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966].

Authors:  E J Sanders; J G Rigau-Pérez; H L Smits; C C Deseda; V A Vorndam; T Aye; R A Spiegel; R S Weyant; S L Bragg
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

5.  Early clinical and laboratory indicators of acute dengue illness.

Authors:  S Kalayanarooj; D W Vaughn; S Nimmannitya; S Green; S Suntayakorn; N Kunentrasai; W Viramitrachai; S Ratanachu-eke; S Kiatpolpoj; B L Innis; A L Rothman; A Nisalak; F A Ennis
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  [Anti-Leptospira antibodies in patients in the State of Mato Grosso do Sul with clinical suspicion of dengue or viral hepatitis].

Authors:  Alda Izabel de Souza; Joseli Maria da Rocha Nogueira; Martha Maria Pereira
Journal:  Rev Soc Bras Med Trop       Date:  2007 Jul-Aug       Impact factor: 1.581

7.  Acute jaundice in Vientiane, Lao People's Democratic Republic.

Authors:  K Bounlu; S Insisiengmay; K Vanthanouvong; S Widjaja; K Iinuma; K Matsubayashi; K Laras; M P Putri; T P Endy; D W Vaughn; B Raengsakulrach; K C Hyams; M Hayden; C Scheffel; A L Corwin
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

8.  Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001-2002.

Authors:  Tania Ellis; Allison Imrie; Alan R Katz; Paul V Effler
Journal:  Vector Borne Zoonotic Dis       Date:  2008-08       Impact factor: 2.133

9.  Detection of leptospiral DNA by PCR.

Authors:  S H Kee; I S Kim; M S Choi; W H Chang
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

Review 10.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

View more
  5 in total

1.  Leptospirosis among Dengue-Negative Febrile Patients in Selangor, Malaysia.

Authors:  Shih Keng Loong; Mohamad Azlan Abd-Majid; Boon Teong Teoh; Mi Jing Cheh; Chee Sieng Khor; Chien Chung Chao; Jing Jing Khoo; Sazaly AbuBakar
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

2.  Leptospirosis diagnosis among patients suspected of dengue fever in Brazil.

Authors:  Felipe Fornazari; Virgínia Bodelão Richini-Pereira; Sâmea Fernandes Joaquim; Pedro Gabriel Nachtigall; Helio Langoni
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-03-26

3.  Assessment of the Current Surveillance System for Human Leptospirosis in Ecuador by Decision Analytic Modeling.

Authors:  María Laura Calero; Gustavo Monti
Journal:  Front Public Health       Date:  2022-03-03

4.  Inflammatory Signatures of Pathogenic and Non-Pathogenic Leptospira Infection in Susceptible C3H-HeJ Mice.

Authors:  Advait Shetty; Suman Kundu; Maria Gomes-Solecki
Journal:  Front Cell Infect Microbiol       Date:  2021-06-24       Impact factor: 5.293

Review 5.  Dengue: 30 years of cases in an endemic area.

Authors:  Daniela Cristina Sensato Monteiro; Natália Vasconcelos de Souza; Jane Cavalcante Amaral; Kaynan Bezerra de Lima; Fernanda Montenegro Carvalho de Araújo; Izabel Letícia Cavalcante Ramalho; Victor Emanuel Pessoa Martins; Jeová Keny Baima Colares; Luciano Pamplona de Góes Cavalcanti; Danielle Malta Lima
Journal:  Clinics (Sao Paulo)       Date:  2019-09-09       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.